Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 231: What is the antidote for cyanide poisoning?

A. Sodium bicarbonate
B. Sodium chloride
C. Sodium thiosulphate (Correct Answer)
D. All of the above

Explanation: **Explanation:** **1. Why Sodium Thiosulphate is Correct:** Cyanide poisoning is life-threatening because cyanide binds to the ferric ($Fe^{3+}$) iron of **cytochrome oxidase a3** in the mitochondria, halting the electron transport chain and causing cellular hypoxia. **Sodium thiosulphate** acts as a sulfur donor. The mitochondrial enzyme **rhodanese** (thiosulfate sulfurtransferase) uses this sulfur to convert toxic cyanide into **thiocyanate**, which is non-toxic and easily excreted by the kidneys. It is often used in combination with nitrites or hydroxocobalamin. **2. Why Other Options are Incorrect:** * **Sodium bicarbonate:** This is used to treat metabolic acidosis (which occurs in cyanide poisoning) or as an antidote for TCA/Salicylate toxicity, but it does not neutralize the cyanide ion itself. * **Sodium chloride:** This is a crystalloid used for volume resuscitation and has no pharmacological role in reversing cyanide toxicity. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Cyanide Antidote Kit" components:** 1. **Amyl/Sodium Nitrite:** Induces methemoglobinemia. Methemoglobin has a high affinity for cyanide, forming **cyanmethemoglobin**, which pulls cyanide away from cytochrome oxidase. 2. **Sodium Thiosulphate:** Converts cyanide to thiocyanate. * **Hydroxocobalamin (Vitamin B12a):** Now considered the first-line treatment. It reacts with cyanide to form **cyanocobalamin**, which is safely excreted. * **Clinical Sign:** "Cherry-red" skin discoloration and a characteristic **bitter almond odor** on the breath. * **Mechanism:** Histotoxic hypoxia (Oxygen is present in the blood but cannot be utilized by tissues).

Question 232: Macrocytic anemia is caused by all EXCEPT:

A. Pyrimethamine
B. Methotrexate
C. Pentamidine (Correct Answer)
D. Trimethoprim

Explanation: **Explanation:** The core concept behind this question is the inhibition of **Dihydrofolate Reductase (DHFR)**, an enzyme essential for converting dihydrofolate into tetrahydrofolate. Tetrahydrofolate is a critical cofactor in DNA synthesis; its deficiency leads to impaired nuclear maturation in red blood cells, resulting in **megaloblastic/macrocytic anemia**. **Why Pentamidine is the Correct Answer:** Pentamidine is an antiprotozoal agent used primarily for *Pneumocystis jirovecii* pneumonia and Leishmaniasis. Unlike the other options, its mechanism involves interfering with oxidative phosphorylation and inhibiting DNA/RNA synthesis by binding to the minor groove of DNA. It does **not** inhibit the DHFR enzyme and, therefore, does not cause macrocytic anemia. **Analysis of Incorrect Options:** * **Methotrexate:** A potent human DHFR inhibitor used in cancer and autoimmune diseases. It is the classic cause of drug-induced megaloblastic anemia. * **Pyrimethamine:** An antiprotozoal (used in Toxoplasmosis) that inhibits DHFR. While it has a higher affinity for protozoal enzymes, it can inhibit human DHFR at high doses. * **Trimethoprim:** An antibacterial that inhibits bacterial DHFR. Prolonged use or high doses can cross-react with human DHFR, leading to folate deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Rescue Therapy:** To prevent macrocytic anemia caused by Methotrexate, **Leucovorin (Folinic acid)** is administered. It bypasses the DHFR block. * **Other Drugs causing Macrocytosis:** Phenytoin (interferes with folate absorption), Zidovudine (AZT), and Hydroxyurea (interferes with DNA synthesis). * **Pentamidine Side Effects:** Notable for causing **pancreatic toxicity** (hypoglycemia followed by diabetes), nephrotoxicity, and QT prolongation.

Question 233: Amiodarone belongs to which category of drugs in pregnancy?

A. Category A
B. Category B
C. Category C (Correct Answer)
D. Category D

Explanation: **Explanation:** **Amiodarone** is classified as **Category C** by the FDA (though some older texts and specific clinical guidelines may transition it toward D due to known risks, the standard pharmacological classification remains C). 1. **Why Category C is Correct:** Category C implies that animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans. However, the potential benefits may warrant the use of the drug in pregnant women despite potential risks. Amiodarone contains high iodine content and has a long half-life; it crosses the placenta and can cause **fetal hypothyroidism, goiter, and neurodevelopmental delays**. It is reserved for life-threatening maternal arrhythmias where safer alternatives (like Digoxin or Adenosine) have failed. 2. **Why Incorrect Options are Wrong:** * **Category A:** These drugs have failed to demonstrate a risk to the fetus in the first trimester in controlled human studies (e.g., Folic acid). Amiodarone has documented fetal risks. * **Category B:** Animal studies show no risk, but no human studies exist, or animal studies show risk but human studies do not (e.g., Penicillin). Amiodarone shows toxicity in animal models. * **Category D:** There is positive evidence of human fetal risk, but benefits may be acceptable in life-threatening situations (e.g., Phenytoin, Lithium). While Amiodarone is dangerous, it is traditionally grouped in C because its use is strictly "benefit vs. risk" in emergencies. **High-Yield Clinical Pearls for NEET-PG:** * **Iodine Content:** Amiodarone is 37% iodine by weight, leading to thyroid dysfunction (Wolff-Chaikoff effect or Jod-Basedow phenomenon). * **Drug of Choice:** For maternal SVT in pregnancy, **Adenosine** is the drug of choice. * **Corneal Micro-deposits:** A classic side effect of Amiodarone (seen in almost all patients on long-term therapy). * **Pulmonary Fibrosis:** The most serious long-term toxicity of Amiodarone.

Question 234: Good clinical practice (GCP) is followed in all of the following phases of drug development EXCEPT:

A. Preclinical trials (Correct Answer)
B. Phase I trials
C. Phase II trials
D. Phase IV trials

Explanation: The core concept to understand here is the distinction between **Good Clinical Practice (GCP)** and **Good Laboratory Practice (GLP)**. **Why Preclinical Trials is the correct answer:** Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials that involve **human participants**. Preclinical trials are conducted in *in vitro* (cell culture) and *in vivo* (animal) models to assess safety and biological activity before human exposure. Therefore, preclinical trials follow **Good Laboratory Practice (GLP)**, not GCP. **Why the other options are incorrect:** * **Phase I, II, and IV trials:** These are all stages of **Clinical Trials**. Since they involve human subjects—ranging from healthy volunteers (Phase I) to large patient populations (Phase II, III) and post-marketing surveillance (Phase IV)—they must strictly adhere to GCP guidelines to ensure the rights, safety, and well-being of the participants are protected and that the clinical data is credible [1]. **High-Yield Clinical Pearls for NEET-PG:** * **GCP Guidelines:** Originally formulated by the **ICH** (International Council for Harmonisation). * **GLP (Good Laboratory Practice):** Applies to non-clinical safety studies (Preclinical). * **GMP (Good Manufacturing Practice):** Applies to the consistent production and quality control of the drug product itself. * **Phase 0 (Microdosing):** The earliest clinical phase in humans; it also requires GCP compliance [1]. * **Declaration of Helsinki:** The fundamental document on ethical principles for medical research involving human subjects, which forms the basis of GCP.

Question 235: Macrocytic anemia is noted with all of the following drugs except:

A. Phenytoin
B. Methotrexate
C. Pyrimethamine
D. Ciprofloxacin (Correct Answer)

Explanation: **Explanation:** Macrocytic anemia (specifically megaloblastic anemia) is primarily caused by interference with DNA synthesis, often due to a deficiency or inhibition of **Folic acid (Vitamin B9)** or **Vitamin B12**. **Why Ciprofloxacin is the correct answer:** Ciprofloxacin is a fluoroquinolone that acts by inhibiting bacterial DNA gyrase and topoisomerase IV. Unlike the other options, it does not interfere with human folate metabolism or DNA synthesis in bone marrow precursors. Therefore, it does not cause macrocytic anemia. **Analysis of Incorrect Options:** * **Phenytoin:** This antiepileptic drug causes macrocytic anemia by interfering with the intestinal absorption of dietary folates and increasing the catabolism of serum folate. * **Methotrexate:** A potent dihydrofolate reductase (DHFR) inhibitor. It prevents the conversion of dihydrofolate to tetrahydrofolate (the active form), directly halting DNA synthesis. * **Pyrimethamine:** Similar to methotrexate, this is a DHFR inhibitor used in treating malaria and toxoplasmosis. While it has a higher affinity for protozoal enzymes, high doses can inhibit human DHFR, leading to megaloblastic changes. **NEET-PG High-Yield Pearls:** * **Other drugs causing Macrocytic Anemia:** Trimethoprim, Zidovudine (AZT), 5-Fluorouracil, Hydroxyurea, and Metformin (via B12 malabsorption). * **Rescue Therapy:** To prevent methotrexate-induced macrocytic anemia/toxicity, **Leucovorin (Folinic acid)** is administered, as it bypasses the inhibited DHFR enzyme. * **Phenytoin Side Effects (Mnemonic: PHENYTOIN):** **P**-P450 inducer, **H**-Hirsutism, **E**-Enlarged gums (Gingival hyperplasia), **N**-Nystagmus, **Y**-Yellow-brown skin, **T**-Teratogenicity (Fetal Hydantoin Syndrome), **O**-Osteomalacia, **I**-Interference with B9 (**Megaloblastic Anemia**), **N**-Neuropathy.

Question 236: What drug is used in the management of scorpion bites?

A. EDTA
B. Neostigmine
C. N-acetylcysteine
D. Prazosin (Correct Answer)

Explanation: **Explanation:** The correct answer is **Prazosin**. **Why Prazosin is the drug of choice:** Scorpion venom (specifically from the Indian Red Scorpion, *Mesobuthus tamulus*) causes a massive release of endogenous catecholamines (epinephrine and norepinephrine), leading to a "sympathetic storm." This results in severe hypertension, myocardial dysfunction, and pulmonary edema. **Prazosin** is a selective **alpha-1 adrenergic blocker**. It acts as a "pharmacological antidote" by: 1. Reducing peripheral vascular resistance (afterload). 2. Decreasing preload by venous dilation. 3. Suppressing the effects of excessive catecholamines, thereby preventing and treating pulmonary edema. **Why other options are incorrect:** * **EDTA (Ethylene Diamine Tetraacetic Acid):** This is a chelating agent used primarily for heavy metal poisoning, such as lead toxicity. * **Neostigmine:** An acetylcholinesterase inhibitor used in Myasthenia Gravis or to reverse neuromuscular blockade. While scorpion stings can have cholinergic effects, Neostigmine would worsen the "cholinergic crisis" phase. * **N-acetylcysteine (NAC):** This is the specific antidote for Acetaminophen (Paracetamol) toxicity, acting by replenishing glutathione stores. **Clinical Pearls for NEET-PG:** * **Dosing:** In scorpion stings, Prazosin is given at 30 micrograms/kg/dose. * **Observation:** The patient must be monitored for the "first-dose effect" (postural hypotension). * **Avoid Steroids/Antihistamines:** These have no proven role in scorpion envenomation and may worsen the clinical picture. * **Scorpion Venom:** It acts on sodium channels, keeping them open and causing persistent depolarization of nerves.

Question 237: Which of the following is the most reliable clinical endpoint to indicate adequate atropinization in organophosphate poisoning?

A. Pupillary dilatation
B. Control of diarrhea
C. Heart rate more than or equal to 100 beats/min
D. Absence of pulmonary secretions (Correct Answer)

Explanation: **Explanation:** In Organophosphate (OP) poisoning, death primarily occurs due to **respiratory failure**, caused by a combination of excessive bronchial secretions, bronchospasm (muscarinic effects), and respiratory muscle paralysis (nicotinic effects). Atropine is a competitive muscarinic antagonist used to reverse the "killer B’s": **B**ronchorrhea and **B**ronchospasm. **Why "Absence of pulmonary secretions" is the correct answer:** The primary goal of atropinization is to ensure a clear airway and adequate oxygenation. The drying up of pulmonary secretions (clear breath sounds on auscultation) is the most critical clinical endpoint because it directly correlates with the reversal of life-threatening respiratory distress. **Analysis of Incorrect Options:** * **A. Pupillary dilatation:** While Mydriasis occurs with atropine, it is an unreliable sign. Pupils may remain constricted due to local OP exposure or dilate before the lungs are clear. * **B. Control of diarrhea:** Gastrointestinal motility is a minor muscarinic effect; its resolution does not guarantee the reversal of life-threatening pulmonary toxicity. * **C. Heart rate ≥ 100 beats/min:** Tachycardia is a sign of atropinization, but it can be misleading. In OP poisoning, tachycardia may already be present due to nicotinic stimulation or hypoxia, making it an unreliable endpoint for titration. **High-Yield Clinical Pearls for NEET-PG:** 1. **Endpoints of Atropinization:** Clear lung sounds (most important), Heart rate >80-100 bpm, and Systolic BP >80 mmHg. 2. **Atropine vs. Oximes:** Atropine treats **muscarinic** symptoms only. It has no effect on **nicotinic** symptoms (muscle fasciculations/paralysis). Oximes (Pralidoxime) are required to reactivate the acetylcholinesterase enzyme. 3. **The "Atropine Challenge":** If OP poisoning is suspected, 1mg of Atropine is given IV. If no signs of atropinization (tachycardia/mydriasis) appear, the diagnosis is confirmed.

Question 238: Ravulizumab is a new drug approved for the treatment of which condition?

A. Paroxysmal nocturnal hemoglobinuria (Correct Answer)
B. Sickle cell anemia
C. Acute hepatic porphyria
D. Meningococcal infections

Explanation: **Explanation:** **Ravulizumab** is a long-acting monoclonal antibody that inhibits the **complement protein C5**. It is a second-generation terminal complement inhibitor, developed as an improvement over Eculizumab. 1. **Why Option A is correct:** **Paroxysmal Nocturnal Hemoglobinuria (PNH)** is characterized by a deficiency of CD55 and CD59 on red blood cells, making them susceptible to complement-mediated hemolysis. Ravulizumab binds to C5, preventing its cleavage into C5a and C5b, thereby blocking the formation of the Membrane Attack Complex (MAC). Its primary advantage over Eculizumab is its **extended half-life**, allowing for maintenance dosing every 8 weeks instead of every 2 weeks. 2. **Why the other options are incorrect:** * **Option B (Sickle cell anemia):** Managed with Hydroxyurea, L-glutamine, or Crizanlizumab (a P-selectin inhibitor). * **Option C (Acute hepatic porphyria):** Treated with **Givosiran**, an siRNA that targets aminolevulinic acid synthase 1 (ALAS1). * **Option D (Meningococcal infections):** This is actually a **contraindication/risk**. Because Ravulizumab inhibits terminal complement, patients are at a 1,000-fold increased risk of life-threatening *Neisseria meningitidis* infections. Vaccination is mandatory before starting therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Humanized monoclonal antibody against C5. * **Indications:** PNH and Atypical Hemolytic Uremic Syndrome (aHUS). * **Key Difference:** Ravulizumab has a "recycling" mechanism (pH-dependent binding) that gives it a much longer duration of action than Eculizumab. * **Black Box Warning:** Meningococcal infection; patients must receive the meningococcal vaccine at least 2 weeks before the first dose.

Question 239: What is a counterfeit drug?

A. A fake medicine
B. A medicine containing the wrong ingredient
C. A medicine with the active ingredient in the wrong dose
D. All of the above (Correct Answer)

Explanation: A **counterfeit drug** is defined by the World Health Organization (WHO) as a pharmaceutical product that is deliberately and fraudulently mislabeled with respect to its identity and/or source. It is essentially a "fake" medicine designed to deceive the consumer and the healthcare provider.Why Option D is Correct:The definition of counterfeiting is broad and covers several scenarios involving the falsification of a drug's composition: **A (Fake medicine):** This includes products that contain no active pharmaceutical ingredient (API) at all (e.g., a pill made only of starch or chalk). **B (Wrong ingredient):** This occurs when a cheaper or different chemical is substituted for the actual drug (e.g., substituting paracetamol for a high-cost antibiotic). **C (Wrong dose):** This involves products that contain the correct API but in sub-therapeutic amounts (to save costs) or toxic amounts (due to poor manufacturing standards).Since all three scenarios describe different methods of pharmaceutical fraud, **"All of the above"** is the correct choice.Clinical Pearls for NEET-PG: **Counterfeit vs. Spurious:** In the Indian context (Drugs and Cosmetics Act), the term **"Spurious"** is often used synonymously with counterfeit. **Public Health Impact:** Counterfeit drugs lead to treatment failure, drug resistance (especially in the case of sub-therapeutic doses of antibiotics/antimalarials), and potential toxicity from unknown impurities. **Identification:** Counterfeiting can apply to both generic and branded products and often involves sophisticated packaging that mimics the original manufacturer.

Question 240: Which is the longest-acting antihistamine?

A. Terfenadine (Correct Answer)
B. Astemizole
C. Fexofenadine
D. Cetirizine

Explanation: **Explanation:** The correct answer is **Terfenadine**. While modern clinical practice has largely replaced it, in the context of classical pharmacology and competitive examinations, Terfenadine is recognized for its exceptionally long duration of action. **1. Why Terfenadine is correct:** Terfenadine is a second-generation H1-antihistamine. Its long duration of action (often exceeding 24 hours) is attributed to its high affinity for H1 receptors and its slow dissociation rate from these receptors. However, it is a prodrug that must be metabolized by the CYP3A4 enzyme into its active metabolite, fexofenadine. **2. Analysis of incorrect options:** * **Astemizole:** Also a long-acting second-generation antihistamine, but its duration is generally considered slightly shorter or comparable to terfenadine in standardized pharmacological classifications. Like terfenadine, it was withdrawn due to cardiotoxicity. * **Fexofenadine:** This is the active metabolite of terfenadine. It is safer because it does not block cardiac potassium channels, but it has a shorter half-life (approx. 14 hours) compared to its parent drug. * **Cetirizine:** A potent second-generation antihistamine with a duration of action of approximately 24 hours. While effective, it does not surpass the receptor-binding persistence of terfenadine. **3. NEET-PG High-Yield Pearls:** * **Cardiotoxicity:** Both Terfenadine and Astemizole were withdrawn from the market because they block **HERG potassium channels**, leading to **QT interval prolongation** and a fatal polymorphic ventricular tachycardia known as **Torsades de Pointes**. * **Drug Interactions:** Toxicity is precipitated when these drugs are co-administered with **CYP3A4 inhibitors** (e.g., Ketoconazole, Erythromycin, Clarithromycin, or Grapefruit juice), which prevent their metabolism and lead to toxic systemic levels. * **Fexofenadine** is the "non-cardiotoxic" alternative to Terfenadine.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free